Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy for Non-metastatic NSCLC
NCT01860040Phase 2Terminated
- Sponsor
- Western Regional Medical Center
- Start
- Apr 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cisplatin, pemetrexed and gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Western Regional Medical Center. Started Apr 2013; status: terminated.
02
Drugs
cisplatinpemetrexedgemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01860040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860040.